Isothermal amplification methods offer several advantages over other technologies. They are inexpensive, have a high efficiency and can be automated. Their speed is another advantage, however, speed isn't always a benefit. For example, PCR uses a low-cost dye to detect amplification products, which may not be suitable for some applications. Moreover, isothermal techniques are less expensive and may require fewer samples. Isothermal nucleic acid amplification technology (INAAT) can detect pathogens in environmental, clinical, and food samples. As a result, they are ideal for diagnostic purposes, such as infection detection. Recent studies show that this technology is useful for diagnosing diseases like HIV and AIDS, and as it is unbiased, isothermal nucleic acid amplification technology (INAAT) also provides higher amounts of DNA material for downstream analysis. Also as this this technology is a fast and inexpensive method, it has many other benefits as well.
The growth of isothermal nucleic acid amplification technology (INAAT) is expected to be driven by a number of factors. The geriatric population is projected to grow significantly in the coming years, along with the growing healthcare infrastructure. Furthermore, the technology can be used to detect rare diseases. It is also useful for biotechnology companies to increase the production of gene therapy drugs. The growing number of patients with chronic illnesses worldwide is driving the demand for this technique.
Isothermal Nucleic Acid Amplifiers are highly sensitive and reliable. The technology is used for a range of diagnostic applications, including infectious diseases and chronic diseases. The researchers who created this technique have been published in a variety of scientific journals. Some of them have even published a case study using this method to detect a rare pathogen in rivers. With Isothermal Amplification Technology, doctors can quickly test a variety of different organisms and diseases with minimal efforts. In February 2022, Seegene, a Korean manufacturer of in vitro-diagnostic products received the CE-IVD mark for its Allplex SARS-CoV-2 fast MDx Assay, an isothermal amplication test that gives results in 30 minutes.
